OTCMKTS:BICX
BioCorRx Inc Stock News
$0.730
+0 (+0%)
At Close: May 31, 2024
BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and Schizophrenia
08:30am, Wednesday, 03'rd Apr 2024
ANAHEIM, CA, April 03, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer of innovative treatment programs for substance use and related disord
BioCorRx Reports Business Update for 2023
08:30am, Tuesday, 02'nd Apr 2024
ANAHEIM, CA, April 02, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and
ANAHEIM, CA, Feb. 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance use and r
BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors
09:52am, Thursday, 08'th Feb 2024
ANAHEIM, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and r
BioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President
08:30am, Tuesday, 09'th Jan 2024
ANAHEIM, CA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and r
BioCorRx Reports Business Update for the Third Quarter of 2023
12:52pm, Tuesday, 14'th Nov 2023
ANAHEIM, CA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and r
Company Hopes in 30 Days to Begin Making Its Drug Candidate Available to Help Patients and Address Public Health Crisis ANAHEIM, CA, Aug. 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx In
BioCorRx Reports Business Update for the Second Quarter of 2023
04:34pm, Monday, 14'th Aug 2023
On Track to Meet 2023 Regulatory Milestones ANAHEIM, CA, Aug. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative
ANAHEIM, CA, July 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and r
BioCorRx to Present at Sequire Biotechnology Conference on February 2nd
08:30am, Friday, 27'th Jan 2023
Presentation on Thursday, February 2, 2023 at 2:00 PM ET
BioCorRx to Present at the LD Micro Main Event XV on October 25th
11:30am, Monday, 24'th Oct 2022
Anaheim, California--(Newsfile Corp. - October 24, 2022) - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of innovative treatment programs for substance abuse and related disord
BioCorRx to Present at the H.C. Wainwright 24th Annual Global Investment Conference
09:30am, Tuesday, 06'th Sep 2022
ANAHEIM, CA, Sept. 06, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and
BioCorRx to Present at the H.C. Wainwright 24th Annual Global Investment Conference
08:30am, Tuesday, 06'th Sep 2022
ANAHEIM, CA, Sept. 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and
BioCorRx to Present at the LD Micro Invitational XII on June 7th
09:00am, Tuesday, 31'st May 2022
ANAHEIM, CA, May 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and
BioCorRx to Participate in Two Upcoming Conferences
08:30am, Tuesday, 22'nd Mar 2022
ANAHEIM, CA, March 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse a
